ID   AMOS-III
AC   CVCL_0E45
SY   AMOS III; AII MS Oral Squamous cell carcinoma-III
DR   Wikidata; Q54749825
RX   Patent=US6730514;
RX   PubMed=13679204;
CC   Group: Patented cell line.
CC   Population: Indian.
CC   Doubling time: 34-36 hours (PubMed=13679204).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Val173Alafs*180 (c.518insC); Zygosity=Unspecified (PubMed=13679204).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
RX   Patent=US6730514;
RA   Ralhan R., Kaur J.;
RT   "Stable human oral cancer cell carcinoma cell line.";
RL   Patent number US6730514, 04-May-2004.
//
RX   PubMed=13679204; DOI=10.1016/S1368-8375(03)00084-8;
RA   Kaur J., Ralhan R.;
RT   "Establishment and characterization of a cell line from smokeless
RT   tobacco associated oral squamous cell carcinoma.";
RL   Oral Oncol. 39:806-820(2003).
//